| SCHEDULE OF NET SALES BY MARKET |
SCHEDULE OF NET SALES BY MARKET
| | |
| | | |
| | | |
| 1 | | |
| | |
| | |
Three Months Ended March 31, 2026 | |
| | |
Product/ Service Transferred Over Time | | |
Product Transferred at Point in Time | | |
Noncash Consideration1 | | |
Total Net Sales by Market | |
| Medical Device | |
$ | 6,679 | | |
$ | 1,490 | | |
$ | 742 | | |
$ | 8,911 | |
| Medical Imaging | |
| 8,006 | | |
| 1,867 | | |
| 3 | | |
| 9,876 | |
| Industrial | |
| 3,689 | | |
| 3,018 | | |
| 175 | | |
| 6,882 | |
| Aerospace and Defense | |
| 4,254 | | |
| 356 | | |
| 37 | | |
| 4,647 | |
| Total net sales | |
$ | 22,628 | | |
$ | 6,731 | | |
$ | 957 | | |
$ | 30,316 | |
| | |
Product/ Service Transferred Over Time | | |
Product Transferred at Point in Time | | |
Noncash Consideration1 | | |
Total Net Sales by Market | |
| | |
Three Months Ended March 31, 2025 | |
| | |
Product/ Service Transferred Over Time | | |
Product Transferred at Point in Time | | |
Noncash Consideration1 | | |
Total Net Sales by Market | |
| Medical Device | |
$ | 5,772 | | |
$ | 1,730 | | |
$ | 568 | | |
$ | 8,070 | |
| Medical Imaging | |
| 6,708 | | |
| 1,873 | | |
| 7 | | |
| 8,588 | |
| Industrial | |
| 4,706 | | |
| 2,132 | | |
| 107 | | |
| 6,945 | |
| Aerospace and Defense | |
| 2,782 | | |
| 478 | | |
| 32 | | |
| 3,292 | |
| Total net sales | |
$ | 19,968 | | |
$ | 6,213 | | |
$ | 714 | | |
$ | 26,895 | |
| 1 |
Noncash
consideration represents material provided by the customer used in the manufacturing of the product. |
|
| SCHEDULE OF CONTRACT ASSETS |
SCHEDULE OF CONTRACT ASSETS
| Balance as of December 31, 2025 | |
$ | 15,184 | |
| Increase (decrease) attributed to: | |
| | |
| Amounts transferred over time to contract assets | |
| 22,628 | |
| Allowance for current expected credit losses | |
| - | |
| Amounts invoiced during the period | |
| (21,802 | ) |
| Balance outstanding as of March 31, 2026 | |
$ | 16,010 | |
|